Cargando…

“Patients with amyotrophic lateral sclerosis (ALS) are usually nice persons”—How physicians experienced in ALS see the personality characteristics of their patients

INTRODUCTION: Physicians experienced in the treatment of patients with amyotrophic lateral sclerosis (ALS) occasionally describe these patients as “nice” persons. METHODS: ALS experienced physicians (n = 36) were asked to assess the personality characteristics of ALS patients using a multidimensiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehl, Theresa, Jordan, Berit, Zierz, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256182/ https://www.ncbi.nlm.nih.gov/pubmed/28127517 http://dx.doi.org/10.1002/brb3.599

Ejemplares similares

Are people with amyotrophic lateral sclerosis (ALS) particularly nice? An international online case–control study of the Big Five personality factors
por: Parkin Kullmann, Jane A., et al.
Publicado: (2018)

Personality factors in patients with myasthenia gravis: A prospective study
por: Jordan, Berit, et al.
Publicado: (2023)

Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge
por: Morgan, Stephen, et al.
Publicado: (2018)

Advance care planning in amyotrophic lateral sclerosis (ALS): study protocol for a qualitative longitudinal study with persons with ALS and their family carers
por: Vandenbogaerde, Isabel, et al.
Publicado: (2022)

Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
por: Sebastião, Ana M., et al.
Publicado: (2018)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
por: Kuan, Li-Hao, et al.
Publicado: (2023)

Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
por: Park, Jin-Mo, et al.
Publicado: (2019)

MRI Study of Paraspinal Muscles in Patients with Amyotrophic Lateral Sclerosis (ALS)
por: Diamanti, Luca, et al.
Publicado: (2020)

State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance
por: Wagner, Laurie, et al.
Publicado: (2016)

Implementation and evaluation of an e-health innovation for personalized care for patients with amyotrophic lateral sclerosis (ALS): protocol for a participatory action research study
por: Dontje, M. L., et al.
Publicado: (2021)

Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)
por: Ferrer-Donato, Agueda, et al.
Publicado: (2021)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
por: Yunusova, Yana, et al.
Publicado: (2011)

Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
por: Seki, Soju, et al.
Publicado: (2023)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models
por: Maksimovic, Katarina, et al.
Publicado: (2023)

Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
por: Mavlyutov, Timur A., et al.
Publicado: (2015)

Amyotrophic Lateral Sclerosis (ALS) Awareness Month — May 2013
Publicado: (2013)

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
por: Fournier, Christina N.
Publicado: (2022)

Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Yunusova, Yana, et al.
Publicado: (2016)

Validation of Clinical Observations of Mastication in Persons with ALS
por: Simione, Meg, et al.
Publicado: (2016)

Face and content validation of the amyotrophic lateral sclerosis—Bulbar dysfunction index (ALS-BDI)
por: Yunusova, Yana, et al.
Publicado: (2023)

Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients
por: Burkhardt, Christian, et al.
Publicado: (2017)

The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea
por: Vogt, Susanne, et al.
Publicado: (2019)

Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia
por: Uenal, Hatice, et al.
Publicado: (2014)

Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan
por: Yu, Yu, et al.
Publicado: (2014)

ALS2 mutations: Juvenile amyotrophic lateral sclerosis and generalized dystonia
por: Sheerin, Una-Marie, et al.
Publicado: (2014)

Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
por: Trojsi, Francesca, et al.
Publicado: (2020)

The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)
por: Ferrer‐Donato, Agueda, et al.
Publicado: (2021)

Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS)
por: Halliday, Vanessa, et al.
Publicado: (2021)

Observed and personally experienced discrimination: findings of a cross-sectional survey of physicians and nursing staff
por: Yolci, Arda, et al.
Publicado: (2022)

Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS)
por: López-Gómez, Juan J., et al.
Publicado: (2021)

Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry
por: Mesaros, Maysen, et al.
Publicado: (2021)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)
por: Limpert, Allison S, et al.
Publicado: (2013)

Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment
por: Schram, Sarah, et al.
Publicado: (2020)

Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
por: Suzuki, Naoki, et al.
Publicado: (2020)

The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
por: Boddy, Sarah L., et al.
Publicado: (2021)

Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: García-García, Raquel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7589fv3fp7g58odt8ohg65ad20